|
TM9SF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.68298749673113E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.9958483450705E-12 |
| Normal-vs-Stage2 |
1.685750E-02 |
| Normal-vs-Stage3 |
3.136900E-03 |
| Normal-vs-Stage4 |
2.378600E-04 |
| Stage1-vs-Stage2 |
4.354600E-01 |
| Stage1-vs-Stage3 |
5.002000E-01 |
| Stage1-vs-Stage4 |
3.552000E-01 |
| Stage2-vs-Stage3 |
8.892000E-01 |
| Stage2-vs-Stage4 |
2.130400E-01 |
| Stage3-vs-Stage4 |
2.481200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.49139597841008E-11 |
| Normal-vs-AfricanAmerican |
9.30809995747239E-09 |
| Normal-vs-Asian |
4.556000E-02 |
| Caucasian-vs-AfricanAmerican |
5.679400E-01 |
| Caucasian-vs-Asian |
3.872000E-01 |
| AfricanAmerican-vs-Asian |
4.656800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.91668902971287E-12 |
| Normal-vs-Female |
4.793800E-04 |
| Male-vs-Female |
5.965900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.77250000232831E-08 |
| Normal-vs-Extreme_Weight |
3.83559850547499E-12 |
| Normal-vs-Obese |
1.54256000000075E-05 |
| Normal-vs-Extreme_Obese |
1.392250E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.677400E-01 |
| Normal_Weight-vs-Obese |
1.520010E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.247600E-01 |
| Extreme_Weight-vs-Obese |
6.417700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.495600E-01 |
| Obese-vs-Extreme_Obese |
4.702400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.45840000000697E-05 |
| Normal-vs-Age(41-60Yrs) |
3.8424999959652E-08 |
| Normal-vs-Age(61-80Yrs) |
2.86299872698237E-11 |
| Normal-vs-Age(81-100Yrs) |
1.174980E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.981830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.596000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.789000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.599400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.894770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.163000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.66866520601161E-13 |
| Normal-VS-Type2 PRCC |
3.80939999999885E-06 |
| Normal-VS-KIRP CIMP |
4.05079969567623E-10 |
| Normal-VS-Unclassified PRCC |
8.728200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.332030E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.961900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.799600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.819600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.263800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.019100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.35829999656923E-08 |
| Normal-vs-N1 |
5.438800E-04 |
| Normal-vs-N2 |
3.93189999999821E-05 |
| N0-vs-N1 |
7.617600E-01 |
| N0-vs-N2 |
7.004400E-01 |
| N1-vs-N2 |
6.085800E-01 |
|
|
